Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Given the severe consequences of alcohol relapse following liver transplantation for alcoholic hepatitis (AH-LT), it is critical to accurately identify alcohol use and implement alcohol interventions early in the post-transplant period to optimize patient outcomes. The proposed randomized clinical trial will examine the implementation and effects of integrated, person- and computer-delivered alcohol treatment compared to standard care on alcohol use (assessed by self-report and biomarker), mood, quality of life and survival following AH-LT. Predictors of 12-month post-transplant alcohol outcomes will be explored to allow future improved tailoring and targeting of these treatments.
Sponsor: Johns Hopkins University
You may qualify if…
- ✓ English speaking
You may not qualify if…
- ✕ too medically/psychiatrically ill to participate
- ✕ not able to provide informed consent due to cognitive impairment
Where it's recruiting
Baltimore
Source: ClinicalTrials.gov · NCT03845205 · last updated 2026-06-09